Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study

N. C. Schaper*, M. Dryden, P. Kujath, D. Nathwani, P. Arvis, P. Reimnitz, J. Alder, I. C. Gyssens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Web of Science)
Original languageEnglish
Pages (from-to)175-186
Issue number1
Publication statusPublished - Feb 2013


  • Antibiotic therapy
  • Diabetic foot infection
  • Fluoroquinolone
  • Moxifloxacin
  • Controlled clinical trial
  • Sequential therapy
  • Diabetic foot ulcer

Cite this